Home › Trials › NCT03492424
Clinical trial Recruiting at 1 site Observational Ages 18 and up Men only

Observational data collection on focal therapies for prostate cancer

Official title: Ablative Therapy in the Management of Prostate Cancer

Run by Weill Medical College of Cornell University · NCT03492424 · Data updated 2026-11-12

This study is collecting information on different focal therapies for prostate cancer to see how well they work and how they affect patients' lives.

More Prostate Cancer trials

Quick facts

Study typeObservational
Ages18 Years and up
SexMen only
Enrollment200 (estimated)
SponsorWeill Medical College of Cornell University
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedJanuary 2, 2018
Main results expectedMarch 2, 2032
Study endsSeptember 2, 2039
Registry record updatedDecember 23, 2025
Trial IDNCT03492424 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are men over 18 years old who are undergoing or have previously received focal therapy for prostate cancer.

Probably not a fit

Patients with clinically evident metastatic disease or those unable to complete an English-language questionnaire may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to gather observational data on the patterns of care and outcomes associated with various focal therapies for prostate cancer, including high-intensity focused ultrasound, cryotherapy, and others. It will utilize both prospective and retrospective registry methods to collect detailed information on patient characteristics, treatment specifics, and oncologic outcomes. Safety and functional outcomes will also be assessed using established classification scales and quality of life questionnaires. The goal is to better understand the effectiveness and safety of these treatment options.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the effectiveness and safety of focal therapies for prostate cancer, potentially improving patient outcomes.

How similar studies have gone: Other studies have shown success with similar observational approaches in assessing treatment outcomes for prostate cancer, indicating that this methodology is both relevant and potentially impactful.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* \>18 years of age
* Undergoing focal therapy for primary or salvage treatment of prostate cancer, or
* Have received prior focal therapy

Exclusion Criteria:

* Clinically-evident metastatic disease
* Unable to fill out an English-language questionnaire

Where it's running

  • Weill Cornell Medicine
    New York, New York, United States     Recruiting

Study contacts

  • Principal investigator: Tim McClure, M.D. — Weill Medical College of Cornell University
  • Study coordinator: Holly Kuczynsk, BS
  • Email: hok4001@med.cornell.edu
  • Phone: 646-962-7523

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Prostate Cancer 1464Weill Medical College of Cornell University 137
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.